{"id":"W2914777901","doi":"10.1200/jco.2019.37.4_suppl.422","title":"Real world eligibility for cabozantinib (C), regorafenib (Reg), and ramucirumab (Ram) in hepatocellular carcinoma (HCC) patients after sorafenib (S).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; BC Cancer Agency; Princess Margaret Cancer Centre; University of Calgary; University of British Columbia; Baker Hughes (Canada)","funders":"","keywords":"Medicine; Regorafenib; Sorafenib; Hepatocellular carcinoma; Cabozantinib; Internal medicine; Ramucirumab; Clinical trial; Pazopanib; Generalizability theory; Oncology; Cancer; Hazard ratio; Confidence interval; Colorectal cancer; Sunitinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004168326,0.0001927297,0.001885395,0.000301487,0.00003812441,0.00003190982,0.0002715382,0.0003279922,0.0002051758],"category_scores_gemma":[0.001452228,0.0001879075,0.0004142249,0.0001647112,0.0001688322,0.0005194623,0.000081103,0.0005340228,0.0000811986],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002329927,"about_ca_system_score_gemma":0.0003135207,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002632756,"about_ca_topic_score_gemma":0.000515879,"domain_scores_codex":[0.9953345,0.00008230798,0.003635633,0.0004538381,0.00005861568,0.0004350751],"domain_scores_gemma":[0.9959622,0.000899567,0.002341987,0.0002999388,0.000208261,0.0002880708],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002686371,0.0005028115,0.9769706,0.00002616071,0.00003872791,0.00001713013,0.0001003332,0.00001677974,0.000003042437,0.007329949,0.0003403678,0.0119677],"study_design_scores_gemma":[0.009162092,0.001985713,0.8997581,0.0000202302,0.00001336526,0.000002645412,0.00002866163,0.0008134584,0.00001797784,0.01584376,0.07214875,0.0002052762],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907733,0.0004901658,0.0001479899,0.001115082,0.001406567,0.0004946374,0.00003741708,0.00000640784,0.005528448],"genre_scores_gemma":[0.9965946,0.0004028905,0.001369391,0.0007974846,0.0003627327,0.00001840161,0.00000329149,0.0000245739,0.0004266401],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07721256,"threshold_uncertainty_score":0.7662647,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08459065596358865,"score_gpt":0.3700940577798194,"score_spread":0.2855034018162307,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}